US biotech firm Novavax on Monday said it had delayed plans to seek authorization for its Covid vaccine candidate, a setback for developing countries hoping the injection would soon be available. The company now hopes to file for authorization in the US and Europe in the third quarter of 2021, it said in a statement, […]